2016
DOI: 10.1177/2053369116680501
|View full text |Cite
|
Sign up to set email alerts
|

The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
30
1
3

Year Published

2017
2017
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(36 citation statements)
references
References 2 publications
2
30
1
3
Order By: Relevance
“…Of the women with breast cancer history, 21% reported use of any CAM/NPI type, which is similar to the usage across the entire cohort. This is in keeping with the recommendation that women with a history of breast cancer should consider non-hormonal options 41 . …”
Section: Discussionsupporting
confidence: 80%
“…Of the women with breast cancer history, 21% reported use of any CAM/NPI type, which is similar to the usage across the entire cohort. This is in keeping with the recommendation that women with a history of breast cancer should consider non-hormonal options 41 . …”
Section: Discussionsupporting
confidence: 80%
“…The findings support current national and international recommendations for individualised prescribing234 and indicate that transdermal HRT should be considered the first choice regimen in women with background risk factors for thrombosis, such as obesity and increased genetic risk.…”
supporting
confidence: 77%
“…This is reflected in current guideline recommendations including from the National Institute for Health and Care Excellence (NICE). 1,3,4 Reassuringly, during a cumulative 18-year follow-up of WHI trials, women taking HRT did not have a higher risk of all-cause, cardiovascular, or cancer mortality.…”
Section: Evidence To Support Hrtmentioning
confidence: 99%